Table 2.
Sample characteristics for the NESDA (stratified by study site) and MOTAR samples.
| NESDA 1 | NESDA 2 | NESDA 3 | MOTAR | Total | |
|---|---|---|---|---|---|
| N | 32 | 57 | 62 | 36 | 187 |
| Age (SD) | 36 (9.52) | 37.26 (10.26) | 35.87 (11.51) | 36.69 (12.37) | 36.48 (10.93) |
| N Female (%) | 19 (59%) | 39 (68%) | 43 (69%) | 23 (66%) | 124 (66%) |
| N MDD (%) (no anx. disorder) | 13 (40%) | 18 (32%) | 22 (35%) | 10 (28%) | 63 (34%) |
| N Anxiety disorder (%) (no MDD) | 11 (34%) | 13 (22%) | 21 (34%) | 2 (6%) | 47 (25%) |
| N Comorbid (%) | 8 (25%) | 26 (45%) | 19 (30%) | 24 (67%) | 77 (41%) |
| Current⁎ IDS (SD) | 22.31 (9.66) | 24.66 (11.45) | 19.93 (12.42) | 15.81 (10.56) | 21.11 (11.96) |
| Current⁎ IDS categorical none/mild/moderate/severe/very severe | 5/16/9/1/1 | 10/18/22/6/1 | 22/20/16/2/2 | 19/10/5/2/0 | 56/64/52/11/4 |
| Current⁎ BAI (SD) | 13.19 (8.45) | 13.33 (9.73) | 13.34 (9.35) | 21.67 (11.95) | 14.91 (10.34) |
| Current⁎ BAI categorical none/mild/moderate/severe | 11/3/7/1 | 22/19/13/3 | 27/18/12/5 | 5/11/11/9 | 65/61/43/18 |
| N in remission (IDS and BAI) | 3 (9%) | 10 (18%) | 16 (25%) | 5 (14%) | 34 (18%) |
| Baseline antidepressant use | 7 (21%) | 20 (35%) | 23 (37%) | 0 (0%) | 50 (26%) |
| Social phobia | 12 (37%) | 23 (40%) | 23 (37%) | 15 (42%) | 73 (39%) |
| Panic with agoraphobia | 6 (18%) | 13 (22%) | 17 (27%) | 8 (22%) | 44 (24%) |
| Panic without agoraphobia | 4 (13%) | 11 (19%) | 9 (15%) | 1 (3%) | 25 (13%) |
| Agoraphobia | 4 (13%) | 3 (5%) | 3 (5%) | 0 (0%) | 10 (5%) |
| GAD | 7 (22%) | 16 (28%) | 15 (24%) | 7 (19%) | 45 (24%) |
Anxiety disorder: one or more of panic disorder, generalized anxiety disorder, social phobia, and agoraphobia. IDS: inventory of depressive symptomatology. BAI: Beck anxiety inventory. GAD: generalized anxiety disorder. IDS categorical cutoffs: 0–13/14–25/26–38/39–48/49–84. BAI categorical cutoffs (Kabacoff et al., 1997): 0–9/10–18/19–29/30–63.
⁎
At the time of scanning.